PAIELLA, SALVATORE
 Distribuzione geografica
Continente #
EU - Europa 4.641
NA - Nord America 4.624
AS - Asia 2.383
AF - Africa 50
SA - Sud America 35
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.751
Nazione #
US - Stati Uniti d'America 4.595
CN - Cina 1.410
GB - Regno Unito 1.152
IT - Italia 845
SG - Singapore 714
SE - Svezia 499
RU - Federazione Russa 495
IE - Irlanda 488
FR - Francia 410
DE - Germania 358
FI - Finlandia 159
HK - Hong Kong 58
UA - Ucraina 58
JP - Giappone 48
NL - Olanda 40
TG - Togo 38
CZ - Repubblica Ceca 34
KR - Corea 33
BE - Belgio 24
TR - Turchia 24
CA - Canada 21
BR - Brasile 20
IN - India 20
VN - Vietnam 20
AU - Australia 12
ID - Indonesia 11
IR - Iran 11
AT - Austria 10
CH - Svizzera 8
DK - Danimarca 7
PL - Polonia 6
ES - Italia 5
GR - Grecia 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
EG - Egitto 4
GH - Ghana 4
KG - Kirghizistan 4
PA - Panama 4
BG - Bulgaria 3
EC - Ecuador 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
IQ - Iraq 3
MX - Messico 3
NO - Norvegia 3
PT - Portogallo 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
UZ - Uzbekistan 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
GI - Gibilterra 1
JO - Giordania 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 11.751
Città #
Southend 1.107
Chandler 1.085
Singapore 596
Dublin 467
Ashburn 332
Beijing 264
Woodbridge 239
Verona 236
Jacksonville 226
Ann Arbor 169
Houston 169
New York 155
Lawrence 150
Princeton 150
Wilmington 132
Boardman 131
Jinan 110
Helsinki 101
Nanjing 92
Shenyang 89
Sindelfingen 75
Seattle 67
Redmond 61
Hong Kong 57
Hebei 55
Fairfield 43
Haikou 42
Hangzhou 42
Milan 42
Tianjin 42
Ningbo 39
Santa Clara 39
Dallas 38
Lomé 38
Bologna 36
Zhengzhou 36
Los Angeles 34
Redwood City 34
Tokyo 34
Nanchang 32
Seoul 32
Washington 32
Changsha 31
Brno 30
Taiyuan 28
Taizhou 27
Moscow 25
Brussels 24
Falls Church 24
Guangzhou 22
Jiaxing 22
San Francisco 19
Norwalk 18
Chicago 17
Amsterdam 16
Kent 16
Rome 16
Fuzhou 15
Dongguan 14
Lancaster 14
Munich 14
Falkenstein 13
Dong Ket 12
Lanzhou 12
Lappeenranta 12
Toronto 12
Cedar Knolls 11
Henderson 11
Menlo Park 11
Jakarta 10
Düsseldorf 9
Genova 9
London 9
Padova 9
Trento 9
Vienna 9
Clearwater 8
Frankfurt am Main 8
Malatya 8
Shanghai 8
Columbus 7
Crugers 7
Foersloev 7
Cambridge 6
Dearborn 6
Foresto 6
Pignone 6
Renton 6
Sant'Ambrogio di Valpolicella 6
São Paulo 6
Atlanta 5
Bolzano 5
Bratislava 5
Buffalo 5
Chions 5
Nuremberg 5
Osaka 5
Paris 5
Phoenix 5
Rimini 5
Totale 7.645
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 357
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 154
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 123
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 120
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 120
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 119
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 118
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 118
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 117
Results of a surveillance protocol for pancreatic BD-IPMNs 116
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 112
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 112
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 109
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 107
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 107
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 107
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 106
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 105
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 105
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 104
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 104
A root-cause analysis of mortality following major pancreatectomy 98
Gα15 in early onset of pancreatic ductal adenocarcinoma 96
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 95
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 94
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 93
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 92
Minimally invasive pancreatic surgery - a review 91
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 91
Delaying surgery for patients with a previous SARS-CoV-2 infection 91
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 90
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 89
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer 89
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 89
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 88
Fhit down-regulation is an early event in pancreatic carcinogenesis 87
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 87
Sex differences in oncogenic mutational processes 87
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 87
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 86
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 84
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 83
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 83
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 83
Surveillance for Pancreatic Cancer in High-Risk Individuals: First-Round Screening Results of a Multicentric Italian Program 81
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 80
Surgery for Distal Cholangiocarcinoma 78
Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 78
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 77
Percutaneous ablation of pancreatic cancer 75
Detection and Treatment of Pancreatic Cancer and High-Grade Precursor Lesions in High-Risk Individuals Undergoing Surveillance: Results From the International CAPS Consortium Registry 74
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 74
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 74
The management of intraductal papillary mucinous neoplasms of the pancreas 74
Postoperative infectious complications as potential negative predictors: Analysis of 600 consecutive pancreaticoduodenectomies 73
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 73
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 73
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 73
Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer 72
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 72
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 72
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 72
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 72
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 71
Tumour thrombosis: an uncommon finding associated with pancreatic tumours 70
US-Guided Percutaneous Radiofrequency Ablation of Locally Advanced Pancreatic Adenocarcinoma: A 5-Year High-Volume Center Experience 70
Perioperative management of patients undergoing pancreatic resection: implementation of a care plan in a tertiary-care center. 69
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 69
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 69
Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study 68
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 68
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 68
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 68
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 68
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 68
Very high serum levels of CA 19-9 in autoimmune pancreatitis: Report of four cases and brief review of literature 67
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 67
Ablation treatments in unresectable pancreatic cancer 67
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 67
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 67
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 66
Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: Case report 65
Prevention and management of complications after ablative therapies on the pancreas 64
Radiofrequency Ablation of Pancreatic Cancer 64
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 64
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. 63
Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality 63
Preoperative fine-needle aspiration of pancreatic neuroendocrine tumors: a reliable tool to assess diagnosis and grading - A prospective single-center analysis of 100 cases 63
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 63
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 63
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 63
Le terapie ablative delle neoplasie pancreatiche 62
ESGAR 2018 Book of Abstracts 61
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 61
Seasonal variations in pancreatic surgery outcome A retrospective time-trend analysis of 2748 Whipple procedures 60
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 60
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 60
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting 59
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 59
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 59
Totale 8.513
Categoria #
all - tutte 51.380
article - articoli 48.433
book - libri 0
conference - conferenze 1.032
curatela - curatele 0
other - altro 164
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.751
Totale 102.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 90 81 97 22 50 50 77 138
2020/20211.237 140 181 56 245 139 121 48 36 60 41 94 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/20251.788 283 273 232 776 224 0 0 0 0 0 0 0
Totale 12.040